Company Viropro Inc. Other OTC

Equities

VPRO

US9282422057

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Inactive Instrument

Viropro, Inc. is engaged in the development and manufacturing of biopharmaceutical drugs. The Company conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The Company intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.

USD in Million	2010	Weight	Delta
Biotherapeutic Proteins 100.0 %	1	100.0 %	-

USD in Million	2010	Weight	Delta
United States 100.0 %	1	100.0 %	-

Members of the board	Title	Age	Since
Ivor Royston BRD	Director/Board Member	79	16-01-07
Michelle L. E. Peake BRD	Director/Board Member	-	12-10-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,170,896,364	1,170,896,364 ( 100.00 %)	0	100.00 %

Viropro, Inc.

2151 O'Toole Avenue Suite 50

95131, San Jose

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.63%	103B
REGENERON PHARMACEUTICALS, INC.	+1.62%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-16.67%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-13.21%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.41%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.57%	12.17B

Bio Therapeutic Drugs